<?xml version='1.0' encoding='utf-8'?>
<document id="30182817"><sentence text="Effect Of epigallocatechin-3-gallate on the pharmacokinetics of amlodipine in rats."><entity charOffset="10-36" id="DDI-PubMed.30182817.s1.e0" text="epigallocatechin-3-gallate" /><entity charOffset="64-74" id="DDI-PubMed.30182817.s1.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.30182817.s1.e0" e2="DDI-PubMed.30182817.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30182817.s1.e0" e2="DDI-PubMed.30182817.s1.e1" /></sentence><sentence text="This study investigates the effect of epigallocatechin-3-gallate (EGCG), a major ingredient of green tea, on the pharmacokinetics of amlodipine in rats"><entity charOffset="38-64" id="DDI-PubMed.30182817.s2.e0" text="epigallocatechin-3-gallate" /><entity charOffset="66-70" id="DDI-PubMed.30182817.s2.e1" text="EGCG" /><entity charOffset="133-143" id="DDI-PubMed.30182817.s2.e2" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.30182817.s2.e0" e2="DDI-PubMed.30182817.s2.e0" /><pair ddi="false" e1="DDI-PubMed.30182817.s2.e0" e2="DDI-PubMed.30182817.s2.e1" /><pair ddi="false" e1="DDI-PubMed.30182817.s2.e0" e2="DDI-PubMed.30182817.s2.e2" /><pair ddi="false" e1="DDI-PubMed.30182817.s2.e1" e2="DDI-PubMed.30182817.s2.e1" /><pair ddi="false" e1="DDI-PubMed.30182817.s2.e1" e2="DDI-PubMed.30182817.s2.e2" /></sentence><sentence text=" The pharmacokinetics of orally administered amlodipine (1 mg/kg) with or without EGCG pretreatment (30 mg/kg/day for 10 days) were investigated"><entity charOffset="45-55" id="DDI-PubMed.30182817.s3.e0" text="amlodipine" /><entity charOffset="82-86" id="DDI-PubMed.30182817.s3.e1" text="EGCG" /><pair ddi="false" e1="DDI-PubMed.30182817.s3.e0" e2="DDI-PubMed.30182817.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30182817.s3.e0" e2="DDI-PubMed.30182817.s3.e1" /></sentence><sentence text=" Plasma concentrations of amlodipine were determined by using a sensitive and reliable liquid chromatography with tandem mass spectroscopy (LC-MS/MS) method"><entity charOffset="26-36" id="DDI-PubMed.30182817.s4.e0" text="amlodipine" /></sentence><sentence text=" The effects of EGCG on the metabolic stability of amlodipine were investigated by using rat liver microsome incubation systems"><entity charOffset="16-20" id="DDI-PubMed.30182817.s5.e0" text="EGCG" /><entity charOffset="51-61" id="DDI-PubMed.30182817.s5.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.30182817.s5.e0" e2="DDI-PubMed.30182817.s5.e0" /><pair ddi="false" e1="DDI-PubMed.30182817.s5.e0" e2="DDI-PubMed.30182817.s5.e1" /></sentence><sentence text=" The results indicated that when the rats were pretreated with EGCG, the Cmax of amlodipine increased from 16"><entity charOffset="63-67" id="DDI-PubMed.30182817.s6.e0" text="EGCG" /><entity charOffset="81-91" id="DDI-PubMed.30182817.s6.e1" text="amlodipine" /><pair ddi="false" e1="DDI-PubMed.30182817.s6.e0" e2="DDI-PubMed.30182817.s6.e0" /><pair ddi="false" e1="DDI-PubMed.30182817.s6.e0" e2="DDI-PubMed.30182817.s6.e1" /></sentence><sentence text="32 ± 2" /><sentence text="57 to 21" /><sentence text="44 ± 3" /><sentence text="56 ng/mL (p &lt; 0" /><sentence text="05), the Tmax decreased from 5" /><sentence text="98 ± 1" /><sentence text="25 to 4" /><sentence text="01 ± 1" /><sentence text="02 h (p &lt; 0" /><sentence text="05), and the AUC0-t increased from 258" /><sentence text="12 ± 76" /><sentence text="25 to 383" /><sentence text="34 ± 86" /><sentence text="95 μg h L-1 (p &lt; 0" /><sentence text="05), which suggested that the pharmacokinetic behavior of amlodipine was affected after oral co-administration of EGCG"><entity charOffset="58-68" id="DDI-PubMed.30182817.s21.e0" text="amlodipine" /><entity charOffset="114-118" id="DDI-PubMed.30182817.s21.e1" text="EGCG" /><pair ddi="false" e1="DDI-PubMed.30182817.s21.e0" e2="DDI-PubMed.30182817.s21.e0" /><pair ddi="false" e1="DDI-PubMed.30182817.s21.e0" e2="DDI-PubMed.30182817.s21.e1" /></sentence><sentence text=" Additionally, the metabolic half-life was prolonged from 31" /><sentence text="3 ± 5" /><sentence text="6 to 52" /><sentence text="6 ± 7" /><sentence text="9 min (p &lt; 0" /><sentence text="05) with the pretreatment of EGCG"><entity charOffset="29-33" id="DDI-PubMed.30182817.s27.e0" text="EGCG" /></sentence><sentence text=" It can be speculated that the drug-drug interaction between EGCG and amlodipine might occur, which might have resulted from the metabolism inhibition of amlodipine by EGCG when they were co-administered"><entity charOffset="61-65" id="DDI-PubMed.30182817.s28.e0" text="EGCG" /><entity charOffset="70-80" id="DDI-PubMed.30182817.s28.e1" text="amlodipine" /><entity charOffset="154-164" id="DDI-PubMed.30182817.s28.e2" text="amlodipine" /><entity charOffset="168-172" id="DDI-PubMed.30182817.s28.e3" text="EGCG" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e0" e2="DDI-PubMed.30182817.s28.e0" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e0" e2="DDI-PubMed.30182817.s28.e1" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e0" e2="DDI-PubMed.30182817.s28.e2" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e0" e2="DDI-PubMed.30182817.s28.e3" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e1" e2="DDI-PubMed.30182817.s28.e1" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e1" e2="DDI-PubMed.30182817.s28.e2" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e1" e2="DDI-PubMed.30182817.s28.e3" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e2" e2="DDI-PubMed.30182817.s28.e2" /><pair ddi="false" e1="DDI-PubMed.30182817.s28.e2" e2="DDI-PubMed.30182817.s28.e3" /></sentence><sentence text="" /></document>